why choose us

First received: August 09, 2023

Clinical Trial: Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+)

Study Status: Completed

Recruit Status: RECRUITING

Condition: NAD

Study Type: INTERVENTIONAL


Official Title: Validation of an Enzymatic Assay for Quantification of Nicotinamide Adenine Dinucleotide in Blood Plasma After Ingestion of the Vitamin B3 Variant Nicotinamide Riboside: a Randomized Controlled Trial

Brief Summary: The investigation is a clinical study in which the impact of taking the dietary supplement nicotinamide riboside (NR) on the concentration of extracellular nicotinamide adenine dinucleotide (eNAD+) in human plasma over time will be determined.The study will be conducted in a randomized, double-blinded, and placebo-controlled manner.

Read more